CD Genomics is a leading biotechnology company providing a full range of services to develop high quality customized aptamers for research, diagnostic and therapeutic applications.
Aptamers are stable single-stranded RNA or DNA oligonucleotides that bind with high affinity and specificity to a wide range of targets such as small organics, peptides, proteins, carbohydrates, small molecules, ions, viruses, cells, and tissues.
Aptamers’ application (Appl. Microbiol. Biotechnol., 2005, Nov 11, 1-8)
Aptamers has been ideal tools in broad applications of research, diagnosis and therapeutics because of several unique properties.
Aptamers have been attracting more and more attention within life science research and applications owing to these advantages over antibody. Aptamers are playing their roles in ELISAS, Westerns, Flow Cytometry & Microarrays and are hopeful to replace antibodies in all of the areas currently dominated by antibodies. Moreover, there is one aptamer approved by FDA and several other candidates are currently in clinical trials. So aptamers possess encouraging prospects.